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Background
Desensitization (DST) has become a cornerstone in the
management of immediate hypersensitivity reactions
(HSRs) to chemotherapic agents. It is the only effective
procedure for overcoming HSRs to first-line therapy,
thus representing an important advance in patients’ treat-
ment and prognosis. Nevertheless, there are still no good
biomarkers to monitor DST safety and effectiveness. The
basophil activation test (BAT) has greater applicability in
difficult cases with inconclusive diagnosis and when
other diagnostic tests (skin tests and serum specific IgE)
have not been standardized, as in drug-induced reactions.
The main goal of our study was to assess BAT as a test to
monitor rapid DST in patients allergic to platins.
Method
We studied 7 oncologic patients who presented platin
allergy and 4 healthy volunteers who had never been
exposed to platins. We performed the BAT immediately
before DST to platins, assessing CD 203c and CD63
expression on basophils. All patients were evaluated at
least in 2 different DST.
Results
BAT was positive in 6 patients (85.7%), with increased
expression of CD203c and CD63 in 6 and 3 patients,
respectively. Subsequent BAT analysis in different DST
procedures showed that the test remained positive with an
even greater expression of CD203c and CD63 on basophils
after platins exposure. Some patients with positive BAT
reacted during DST, in spite of being premedicated, show-
ing the correlation between BAT results and clinical out-
comes. Further investigation is necessary to determine
BAT predictive values and its clinical applicability.
Conclusion
We developed a BAT to platins that presented good sensi-
tivity in our study. Short-term DST to platinum drugs
does not induce persistent hyporresponsiveness on baso-
phils, highlighting the need to maintain DST in allergic
patients to platins.
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